114. Sickle Cell Disease, Sickle Cell Trait, and Other Hemoglobinopathies, Excluding Thalassemias: Clinical and Epidemiological: Poster I

A phase III, multicenter, randomized, placebo controlled, double-blind study to assess efficacy and safety of crizanlizumab (5 mg/kg) versus placebo, with or without hydroxyurea/hydroxycarbamide therapy

An evaluation of the relationship between abnormal myocardial perfusion and diastolic dysfunction in sickle cell disease using PET rest stress myocardial perfusion imaging Mypers

The impact of viral pneumonia on hospital outcomes in sickle cell disease A database review and analysis

Sex related differences in silent cerebral infarction burden among adults with sickle cell disease

Cerebral hemodynamic changes during vaso occlusive episodes in pediatric sickle cell disease

Pilot study on thrombosis risk factors in sickle cell anemia

Seasonal variation in chronic and acute pain in patients with sickle cell disease

Using a magnetic column separator to determine the magnetophoretic behavior and adhesion characteristics of oxygenated sickle and healthy red blood cells

Psychometric evaluation of the self management skills checklist across Brazil and the United States Toward global measurement of transition readiness in sickle cell disease

Mapping activated microglial density in individuals with sickle cell disease utilizing time dependent diffusion weighted MRI and correlation with cognitive performance

Electrocardiographic abnormalities and QTc prolongation in sickle cell disease Insights from the CSSCD cardiac ancillary Study

Keeping it renal Results of applying guideline based management in sickle cell nephropathy

Mean corpuscular hemoglobin modulates HbF distribution and sub phenotypes of sickle cell disease

Splenic dysfunction in young children with sickle cell disease

Is hydroxyurea treatment associated with an increased risk of malignancy in sickle cell disease a propensity matched analysis of 27 854 patients in the real world

Sight Sickle cell identification from general hematological testing a machine learning approach for rapid screening in emergency medicine

Clinical and laboratory findings in adults with sickle cell disease which increase risk for severe acute chest syndrome

The national burden of opoid use disorder on hospital outcomes in sickle cell disease A database review and analysis

Uric acid a potent antioxidant with protective and toxic affects on renal function

Maternal outcomes in sickle cell trait patients hospitalized with preeclampsia and eclampsia

Antibody and equipment free ultralow cost point of care sickle cell disease diagnostic An equitably accessible powerful assay

Prediction model for pediatric return visits for sickle cell disease post emergency department discharge for acute pain

Measles vaccine induced sero protection among children with sickle cell anemia

Sickle cell disease trials redefined Toward unified clinical endpoints through international consensus

Lower neutrophil counts after hematopoietic stem cell transplant for sickle cell disease patients using donors with duffy null phenotype

Effects of vaso occlusive episodes acute kidney injury and APOL1 status on urine albumin concentration in patients with sickle cell disease

Early life anthropometrics predict anthropometrics later in children with sickle cell disease and are different from the general population

Examining the utility of RBC transfusions in uncomplicated vaso occlusive episodes